The UK Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a call for evidence to evaluate the impact of resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and will remain open until 26 February 2027.
The two organisations are seeking feedback from a broad set of stakeholders, including developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers and regulators, as well as people with lived experience of mental health conditions, carers and members of the public.
Scope of the evaluation
According to the MHRA and NICE, the survey forms part of the programme's Phase 1 evaluation. It is intended to assess how the resources have been received and used across the sector, with particular interest in whether the materials have influenced users' knowledge, confidence, decision-making and professional practice.
The resources were developed to support the safe development, regulation, evaluation and adoption of digital mental health technologies, a category that includes mental health apps and other digital tools.
Informing the next phase
Findings from the survey will help determine whether the Phase 1 outputs achieved their intended objectives and will inform the future direction of Phase 2 of the DMHT programme.
The MHRA and NICE state that stakeholders are encouraged to take part whether they have engaged extensively, minimally or not at all with the existing resources. The feedback, they say, will help identify strengths, highlight areas for improvement and shape future work aimed at improving the safety and effectiveness of digital mental health technologies.
Details of the survey are set out in the call for evidence published by the two organisations.